SCHEMBL442158

SCHEMBL442158

Cc1ccc(Cl)c2c(N)c(C(=O)O)cnc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HAVCR2 Q8TDQ0 1/20 0.54
GABRP O00591 3/20 0.44
GABRD O14764 3/20 0.44
GABRA1 P14867 3/20 0.44
GABRB1 P18505 3/20 0.44
GABRG2 P18507 3/20 0.44
GABRB3 P28472 3/20 0.44
GABRA5 P31644 3/20 0.44
GABRA3 P34903 3/20 0.44
GABRA2 P47869 3/20 0.44
GABRB2 P47870 3/20 0.44
GABRA4 P48169 3/20 0.44
GABRE P78334 3/20 0.44
GABRA6 Q16445 3/20 0.44
GABRG1 Q8N1C3 3/20 0.44
GABRG3 Q99928 3/20 0.44
GABRQ Q9UN88 3/20 0.44
KDM4E B2RXH2 4/20 0.43
KMT2A Q03164 2/20 0.43
CLCN2 P51788 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL438132 0.88 GABRP (0.49) HAVCR2GABRPGABRDGABRA1GABRB1
SCHEMBL440068 0.88 HAVCR2 (0.63) HAVCR2GABRPGABRDGABRA1GABRB1
SCHEMBL440196 0.82 NPC1 (0.52) KDM4EKMT2AHTTMEN1MAPK1
SCHEMBL435825 0.82 HAVCR2 (0.50) HAVCR2KDM4EKMT2ACLCN2PDE4A
SCHEMBL437482 0.79 CYP3A4 (0.35) HAVCR2KDM4EKMT2AMEN1LMNA
SCHEMBL7502162 0.78 GABRP (0.41) HAVCR2GABRPGABRDGABRA1GABRB1
SCHEMBL437260 0.78 HAVCR2 (0.67) HAVCR2GABRPGABRDGABRA1GABRB1
SCHEMBL439833 0.76 HAVCR2 (0.53) HAVCR2KDM4EKMT2ACLCN2HTT
SCHEMBL436747 0.75 CYP3A4 (0.32) KDM4EKMT2AMEN1LMNAMAPT
SCHEMBL10482896 0.75 HAVCR2 (0.44) HAVCR2GABRPGABRDGABRA1GABRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120065166-A1 Bone Modulators And Methods Therewith ESPINA VIRGINIA (US) 2012-03-15 US disclosed